Loading...
Phenotypic diversity drives paracrine drug tolerance
Considerable clinical successes have been achieved in cancer treatment since the introduction of targeted therapies. However, almost inevitably tumors develop therapy resistance, which limits durable clinical responses. Tumors are often heterogeneous, and as a result, therapy‐resistant cells are pre...
Saved in:
| Published in: | EMBO Mol Med |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
John Wiley and Sons Inc.
2017
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5538330/ https://ncbi.nlm.nih.gov/pubmed/28694322 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15252/emmm.201707956 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|